New state of the art cleanroom and production facilities for a leading UK MHRA approved and NHS Accredited Specials Manufacturing Company will assist them in their goal of becoming a centre of medical cannabis excellence for the UK.
Multi-disciplinary engineering company WHP were awarded the contract to design, build and validate a state-of-the-art manufacturing pharmaceutical cleanroom and food production facility.
Multi-disciplinary engineering company WHP were awarded the contract to design and build a fully modularised containment facility. The project comprised the design and manufacture of 122 cGMP modules, making it one of the largest modular cGMP facilities in Europe.
Curating their extensive portfolio of process solutions to serve a multitude of cell therapy applications, BioPharma Dynamics are utilising their infrastructure and industry experience, to support the UK’s ever-growing cell and gene therapy sector.
A new survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation.
Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL site”) in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions.